INTRODUCTION
Currently, type 1 diabetes (T1D) is defined by the autoimmune destruction of the pancreatic β cells that culminates in dependence on exogenous insulin, typically 1 to 3 years after diagnosis. This ability to maintain a residual function of pancreatic β cells is, however, heterogeneous, appearing to be worst if the disease is early diagnosed. Recently, it was demonstrated that many type 1 diabetic patients produce small amounts of insulin decades after diagnosis. 
CLINICAL CASES

CASE
DISCUSSION
The residual insulin production, detectable by the assay of C-peptide and its functional and clinical significance have been recently discussed. According to recent evidence, these cases show us that insulin production in type 1 diabetic patients can be kept for many years after diagnosis and that the end of the "honey-moon phase" does not necessarily lead to the absence of insulin production. 
